Coalition for Healthcare Communication Inc

What it reported doing in 2024

Chc solicits funds to support member communications and educational programs about health policy proposals that might impair the ability of member companies to communicate accurate and credible healthcare information that benefits patients and society. Chc defends the right of healthcare professionals and consumers to receive truthful information regarding pharmaceuticals and medical products, as safeguarded by the constitution of the united states. Founded in 1991, the coalition represents organizations, rather than individuals, dedicated to assuring the free exchange of scientific information without undue government interference (see schedule o).the importance of communications in successful medical care cannot be overstated, especially as it relates to the application and use of pharmaceuticals and medical devices. Responsible product promotion and other communications directed to healthcare professionals assure that those who prescribe, administer, and dispense prescription drugs and medical devices, and the patients who use them, will have the information necessary to use these products appropriately, effectively, and safely.the coalition also promotes advocacy objectives by supporting industry and government efforts to ensure that healthcare professionals and consumers have available quality health information and to foster industry-supported information that is ethical and of high quality. The coalition ensures that government laws and regulations:-protect the first amendment right of the healthcare industry and clinicians to disseminate and receive data about health-related products and services.-facilitate the ability of companies to freely communicate factual and truthful information about their products and services to healthcare providers and patients.

Financial Efficiency

• Mission deployment rate: Limited
• Program expense ratio: Limited
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 90%; rating input score 90; 9th percentile among comparable filings
• Pay-setting controls: 0 of 6 controls in place; rating input score 0
  • Compensation committee: Missing
  • Independent consultant: Missing
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Missing
  • Board or committee approval: Missing
• Foreign activity oversight: Limited
• Grant itemization coverage: Limited
• Major donor itemization: Limited
• Related-party transparency: Limited

Accountability

• Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
• Governance controls: 7 of 8 controls in place; rating input score 88
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Fail
  • Other executive compensation review process: NotApplicable
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -1%; rating input score 37; 37th percentile among comparable filings
• Total-asset coverage ratio: 2.13; rating input score 61; 61st percentile among comparable filings
• Liabilities to assets ratio: 0.17; rating input score 21; 21st percentile among comparable filings
• Officer compensation ratio: 78.6%; rating input score 1; 1st percentile among comparable filings

Growth

• Program expense growth: Limited
• Revenue growth: -3% per year; rating input score 0; 14th percentile among comparable filings
• Asset growth: 7% per year; rating input score 100; 56th percentile among comparable filings